$ Value
$129K
Shares
7,597
Price
$17
Filed
Jun 5
Insider
Name
Saggar Rajeev
Title
Chief Medical Officer
CIK
0001935638
Roles
Transaction Details
Transaction Date
2025-06-04
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
273,209
Footnotes
Performance stock units ("PSUs") convert into common stock on a one-for-one basis. | On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer. Of those PSUs, a total of 17,654 have vested through June 3, 2025. | Includes (i) 5,865 unvested restricted stock units ("RSUs") of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 36,458 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 38,838 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. | Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. | These shares were sold to cover taxes associated with the settlement of PSUs that were initially granted to the Reporting Person on January 11, 2024.
Filing Info
Saggar Rajeev's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-13 | LQDA | ▼ | $354K |
| 2026-04-10 | LQDA | M | — |
| 2026-04-10 | LQDA | M | — |
| 2026-04-10 | LQDA | M | $0 |
| 2026-04-10 | LQDA | M | $0 |
| 2026-03-13 | LQDA | ▼ | $1.3M |
| 2026-01-16 | LQDA | A | $0 |
| 2026-01-16 | LQDA | A | $0 |
| 2026-01-12 | LQDA | ▼ | $791K |
| 2026-01-09 | LQDA | M | — |
Other Insiders at LQDA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
JEFFS ROGER
Chief Executive Officer
|
— | $6.0M | 2026-04-17 |
| Bloch Stephen M | — | $2.5M | 2026-03-27 |
| Manning Paul B | — | — | 2026-02-11 |
|
Kaseta Michael
CFO and COO
|
— | $12.8M | 2026-04-15 |
|
Adair Jason
Chief Business Officer
|
— | $330K | 2026-04-13 |
| SINGH RAMAN | — | $721K | 2026-03-13 |
|
Moomaw Scott
Chief Commercial Officer
|
— | $3.9M | 2026-04-13 |
|
Schundler Russell
General Counsel
|
— | $558K | 2026-04-13 |
|
Saggar Rajeev
Chief Medical Officer
|
— | $1.6M | 2026-04-13 |
|
Boyle Dana
Chief Accounting Officer
|
— | $275K | 2026-04-13 |
|
Krepp Sarah
Chief Human Resource Officer
|
— | $801K | 2026-04-13 |